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ABSTRACT 
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the commonest cause of neonatal jaundice in Malay-
sia. Recently, OSMMR2000-D G6PD Assay Kit has been introduced to quantitate the level of G6PD activity in 
newborns delivered in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). As duration of sample stor-
age prior to analysis is one of the matters of concern, this study was conducted to identify the stability of G6PD 
enzyme during storage. A total of 188 cord blood samples from normal term newborns delivered at UKMMC 
were selected for this study. The cord bloods samples were collected in ethylene-diamine-tetra-acetic acid 
(EDTA) tubes and refrigerated at 2-8 °C. In addition, 32 out of 188 cord blood samples were spotted on chroma-
tography paper, air-dried and stored at room temperature. G6PD enzyme activities were measured daily for 
7 days using the OSMMR2000-D G6PD Assay Kit on both the EDTA blood and dried blood samples. The mean 
value for G6PD activity was compared between days of analysis using Student Paired T-Test. In this study, 172 
out of 188 cord blood samples showed normal enzyme levels while 16 had levels corresponding to severe en-
zyme deficiency. The daily mean G6PD activity for EDTA blood samples of newborns with normal G6PD activ-
ity showed a significant drop on the fourth day of storage (p < 0.005) while for samples with severely deficient 
G6PD activity, significant drop was seen on third day of storage (p = 0.002). Analysis of dried cord blood 
showed a significant reduction in enzyme activity as early as the second day of storage (p = 0.001). It was also 
noted that mean G6PD activity for spotted blood samples were lower compared to those in EDTA tubes for all 
days (p = 0.001). Thus, EDTA blood samples stored at 2-8 °C appeared to have better stability in terms of their 
G6PD enzyme level as compared to dried blood samples on filter paper, giving a storage time of up to 3 days.  
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INTRODUCTION 
Glucose-6-Phosphate Dehydrogenase 
(G6PD) is an enzyme in the hexose mono-
phosphate oxidative pathway of the red 
blood cells. The G6PD enzyme maintains the 
production of the cofactor nicotinamide ade-
nine dinucleotide phosphate-oxidase 
(NADPH). NADPH, on the other hand, is 
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important for maintenance of reduced gluta-
thione which involves in detoxifying toxic 
oxidative products in the body. Hence, 
G6PD deficiency results in a loss of this pro-
tective effect and leads to oxidative damage 
of the red cells. This occurs when the affect-
ed individuals are exposed to oxidative stress 
such as infections, certain drugs and foods. 
Most individuals with deficiency in G6PD 
enzyme are asymptomatic (Iranpour et al., 
2003) but may episodically suffer from acute 
haemolytic anemia. However, the most im-
portant complication of G6PD deficiency is 
severe neonatal jaundice which may lead to 
brain damage or even death. 
G6PD deficiency is the commonest en-
zymopathy in human affecting approximate-
ly 400 million individuals worldwide and is 
an X-linked disorder. It has a wide geograph-
ical distribution and is highly prevalent in 
Africa, Mediterranean, Southeast Asia and 
Middle East (Ainoon et al., 2003a; Allahver-
diyev et al., 2012). In Malaysia, the overall 
incidence of G6PD deficiency among males 
is 3.1 %. It was reported to be more common 
among the Chinese and Malays as compared 
to Indians (Ainoon et al., 2003b). A national 
programme of mandatory screening for 
G6PD deficiency of all newborns has been 
instituted since early 1980s, employing the 
WHO recommended semiquantitative Fluo-
rescent Spot Test (FST) because of the asso-
ciation with severe neonatal jaundice (Beut-
ler and Mitchell, 1968). However, the lack of 
sensitivity of the FST to detect individuals 
with moderate enzyme deficiency (activity 
> 20 % < 60 % of normal mean) (Reclos et 
al., 2000; Minucci et al., 2008, Ainoon et al., 
2003a) who are also at risk for severe hae-
molysis, has led us to introduce the quantita-
tive G6PD enzyme assay method at our cen-
tre for routine screening of newborns 
(Ainoon et al., 2003a; Azma et al., 2010). 
Being the sole hospital to offer G6PD assay 
as a service our center has become a referral 
laboratory and have been receiving a sub-
stantial number of samples from other hospi-
tals including state hospitals. One of the 
problems faced by our clients is the effect of 
time and temperature on the enzyme activity 
of the samples during transportation (Castro 
et al., 2005; Odoula et al., 2005) which in 
turn may affect the accuracy and the con-
sistency of the results from outside referred 
samples. Hence, this study was conducted to 
evaluate the stability of G6PD activity in-
vitro and to identify the maximum storage 
time that a sample can be stored and to give 
a consistent reading on different methods of 
storage. 
 
MATERIALS AND METHODS 
One hundred eighty eight neonates (97 
males; 91 females) born at the Universiti 
Kebangsaan Malaysia Medical Centre were 
selected within a period of 4 months study. 
The study was performed on EDTA cord 
blood samples received at the Haematology 
Laboratory, Department of Laboratory Diag-
nostics Service, UKMMC, for routine G6PD 
screening by FST. Informed consents were 
obtained from parents of newborns involved 
in the study. This study was approved by In-
stitutional Human Research Committees of 
UKMMC and Universiti Teknologi MARA, 
Campus Puncak Alam. Red blood cell G6PD 
activity assays were performed on all the 
blood samples in the EDTA tubes. Out of the 
188 cord blood samples, 32 cord blood sam-
ples spotted on chromatography paper and 
air-dried. The G6PD activity assay was done 
daily for seven consecutive days during 
which the EDTA cord blood, stored at 2-
8 °C and the air-dried blood on chromatog-
raphy paper, stored in a dark place at room 
temperature. G6PD assays were performed 
using OSMMR-D G6PD assay kit with hae-
moglobin normalization from R and D Diag-
nostics (Holargos, Greece) and enzyme ac-
tivity measured on a spectrophotometer (Ul-
tramicroplate Reader EL808, Bio Tek, In-
struments) as previously described (Azma et 
al., 2010). For the batch of control samples 
provided by the manufacrurer, a reference 
range of G6PD activity for the newborns was 
established as recommended (Azma et al., 
2010). The mean G6PD activity for the new-
borns with normal G6PD activity was 
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12.8 U/g Hb. The cut-off points for G6PD 
deficiency were established according to 
WHO classification and are as follows: 7.69 
U/g Hb (60 % of normal mean), 2.56 U/g Hb 
for severe deficiency (20 % of normal mean 
activity) and 2.56 to 7.69 U/g Hb being the 
range for moderate deficiency (20 % - 60 % 
of normal mean activity) (Azma et al., 2010). 
 
Statistical analysis 
The statistical analysis was done using 
SPSS version 18.0 software. Daily mean of 
G6PD enzyme activity were analysed using 
Student Paired T-Test. P-value < 0.005 was 
considered statistically significant difference 
in mean of G6PD activity. 
 
RESULTS 
Of the 188 selected newborns, the ethnic 
distribution was Malays 72 % (n = 134), fol-
lowed by Chinese 21 % (n = 40), Indians 
3 % (n = 6) and others 4 % (n = 8). Others 
comprised of Iban, Kadazan, Kayan, Indone-
sia, Myanmar, Pakistan, Sudan and Thai 
origin.  
172/188 (91 %) samples were found to 
have normal G6PD activity and 16/188 
(9 %) were severe deficient. Of the samples 
with normal G6PD activity, 124/172 (66 %) 
were Malays, 35/172 (19 %) Chinese and 
6/172 (4 %) Indians. As for the samples with 
severely G6PD deficiency, 9 (5 %) were Ma-
lays, 5 (3 %) were Chinese and the remain-
ing of 2 (1 %) were Kadazan and Myanmar. 
The daily mean G6PD activity level for 
the 172 newborns with normal G6PD activi-
ty was tabulated in (Figure 1). There was 
slight drop in the enzyme activity after Day 1 
and Day 2 but the reduction demonstrated 
were not statistically significant in the mean 
G6PD activity between Day 1 and Day 2, 
and also between Day 1 and Day 3 
(p = 0.033 and 0.006 respectively) (Table 1). 
However, the mean G6PD activity showed 
statistically significant drop (p < 0.005) on 
the fourth day of storage and onwards. There 
was a statistically significant difference in 
the mean G6PD activity between Day 1 and 
Day 4, and the subsequent days (p < 0.005). 
The differences in the mean of G6PD activi-
ty between Day 1 and Day 7 were 0.842 U/g 
Hb (p < 0.005). 
Figure 2 shows the daily mean G6PD ac-
tivity in the cord blood samples of 16 new-
borns with G6PD deficiency. There was no 
statistically significant differences in the 
means G6PD activity between Day 1 and 
Day 2 (p = 0.327) (Table 2). However, there 
were statistically significant differences in 
the means G6PD activity of G6PD deficient 
newborns between Day 1 and Day 3, and the 
subsequent days (p < 0.005). The differences 
of the means G6PD activity between Day 1 
and Day 7 was 1.459 U/g Hb (p < 0.005). 
 
 
Figure 1: Mean G6PD activity in EDTA cord blood samples from neonates with normal G6PD Activity 
(n = 172) 
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Table 1: Daily mean G6PD activity of blood samples stored in EDTA tube from neonates with normal 
G6PD activity 
Variable Mean (SD) Mean of score difference (95 % CI) t-stats (df) P value 
Pair 1 Day 1 
Day 2 
15.089 (1.325) 
14.972 (1.364) 
0.117 
(0.010 – 0.225) 2.152 (171) 0.033 
Pair 2 Day 1 
Day 3 
15.089 (1.325) 
14.901 (1.425) 
0.188 
(0.054 – 0.322) 2.767 (171) 0.006 
Pair 3 Day 1 
Day 4 
15.089 (1.325) 
14.729 (1.441) 
0.360 
(0.224 – 0.495) 5.222 (171) 0.000 
Pair 4 Day 1 
Day 5 
15.089 (1.325) 
14.387 (1.529) 
0.702 
(0.551 – 0.853) 9.194 (171) 0.000 
Pair 5 Day 1 
Day 6 
15.089 (1.325) 
14.348 (1.436) 
0.741 
(0.590 – 0.892) 9.666 (171) 0.000 
Pair 6 Day 1 
Day 7 
15.089 (1.325) 
14.247 (1.536) 
0.842 
(0.675 – 1.008) 9.957 (171) 0.000 
P-value < 0.005 shows there was significant difference in mean G6PD activity  
 
 
 
Figure 2: Mean G6PD activity in EDTA cord blood samples with deficient G6PD activity (n = 16) 
Table 2: Daily mean G6PD activity of blood samples stored in EDTA tube from neonates with G6PD 
deficiency 
Variable Mean (SD) Mean of score difference (95 % CI) t-stats (df) P value 
Pair 1 Day 1 
Day 2 
3.437 (0.929) 
3.311 (1.038) 0.126 (-0.138 – 0.391) 1.014 (15) 0.327 
Pair 2 Day 1 
Day 3 
3.437 (0.929) 
2.786 (0.967) 0.651 (0.281 – 1.021) 3.747 (15) 0.002 
Pair 3 Day 1 
Day 4 
3.437 (0.929) 
2.554 (0.923) 0.882 (0.481 – 1.284) 4.689 (15) 0.000 
Pair 4 Day 1 
Day 5 
3.437 (0.929) 
2.312 (0.702) 1.126 (0.799 – 1.453) 7.343 (15) 0.000 
Pair 5 Day 1 
Day 6 
3.437 (0.929) 
2.136 (0.755) 1.300 (0.947 – 1.655) 7.827 (15) 0.000 
Pair 6 Day 1 
Day 7 
3.437 (0.929) 
1.977 (0.756) 1.459 (1.039 – 1.881) 7.388 (15) 0.000 
P-value < 0.005 shows there was significant difference in mean G6PD activity  
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Figure 3 shows the changes in the daily 
mean G6PD activities in the 32 cord blood 
spotted and air-dried on chromatography pa-
per. The G6PD activity appeared to drop 
from Day 1 to Day 4 of analysis, but on 
Day 5, the activity was slightly increased be-
fore it dropped again on Day 6 and Day 7. 
The differences in the mean G6PD activity 
between Day 1 and Day 7 were 4.628 U/g 
Hb (p < 0.005). Statistically significant dif-
ferences in G6PD activity were observed be-
tween Day 1 and Day 2, and onwards 
(p < 0.005) (Table 3). 
DISCUSSION  
Routine testing for G6PD deficiency by 
FST has been shown to miss substantial pro-
portion G6PD deficient individuals who 
have moderate enzyme deficiency (Ainoon et 
al., 2003a). They were mostly female hetero-
zygotes who were classified as partially defi-
cient. However, they had been shown to be 
at risk to haemolyis and severe neonatal 
jaundice. The enzyme assay method for the 
quantitation of RBC G6PD activity was in-
troduced in UKMMC as a service since 2010  
 
 
 
Figure 3: Comparison of daily mean G6PD activity between stored blood from EDTA tube and stored 
blood spots on chromatography paper (n = 32).  
 
Table 3: Comparison of daily mean G6PD activity between blood samples from EDTA tube and air 
dried blood spot on chromatography paper 
Variable Mean (SD) Mean of score difference (95 % CI) t-stats (df) P value 
Day 1 EDTA 
Air-dry 
15.954 (1.144) 
13.964 (2.851) 1.990 (0.852 – 3.128) 3.566 (31) 0.001 
Day 2 EDTA 
Air-dry 
15.871 (1.186) 
12.026 (2.236) 3.845 (2.870 – 4.821) 8.042 (31) 0.000 
Day 3 EDTA 
Air-dry 
15.761 (1.137) 
11.206 (2.346) 4.555 (3.568 – 5.542) 9.413 (31) 0.000 
Day 4 EDTA 
Air-dry 
15.565 (1.157) 
10.734 (2.157) 4.831 (3.913 – 5.749) 10.730 (31) 0.000 
Day 5 EDTA 
Air-dry 
14.791 (1.256) 
11.657 (2.677) 3.134 (1.988 – 4.280) 5.577 (31) 0.000 
Day 6 EDTA 
Air-dry 
14.653 (0.984) 
10.904 (2.209) 3.749 (2.770 – 4.728) 7.808 (31) 0.000 
Day 7 EDTA 
Air-dry 
14.581 (1.138) 
9.336 (1.797) 5.246 (4.474 – 6.017) 13.859 (31) 0.000 
P-value < 0.005 shows there was significant difference in mean G6PD activity 
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to address this problem. Due to the scarcity 
of hospitals providing this service and the 
realization of the importance of G6PD activi-
ty measurement as part of strategy of preven-
tion of severe neonatal jaundice associated 
with G6PD deficiency, UKMMC laboratory 
has offered this service to other hospitals. 
EDTA cord blood samples were currently 
transported from state hospitals to UKMMC. 
Most of the time it involves extended period 
of time, may exceed 24 hours due to long 
distance. Hence, inappropriate storage may 
affect the stability of G6PD enzyme and 
jeopardizing the accuracy of the measure-
ment of the G6PD activity level.  
In the present study we found that G6PD 
activity measurement of cord blood samples 
in EDTA tube, when stored at 2-8 °C, began 
to show slight drop after Day 1. However, a 
significant drop was only seen on fourth day 
and the subsequent days for the samples 
from newborns with normal G6PD activity. 
There were statistically significant differ-
ences in the means of G6PD activity be-
tween Day 1 and Day 4 onwards p < 0.005 
(Figure 1 and Table 1). These findings seem 
to be consistent with the findings by Castro 
et al. (2005). In their works, they found that 
G6PD enzyme activity for blood samples in 
EDTA tube stored refrigerated at 2-8 °C 
gave consistent reading for G6PD activity up 
to 72 hours from time of collection.  
As for the severe G6PD deficiency 
group, the enzyme activity appeared to be 
reduced also seen after Day 1, but significant 
drop was detected much earlier as compared 
to the normal G6PD group. A significant 
drop was seen starting Day 3 onwards. It was 
shown that the means of G6PD activity on 
Day 1 was 3.42 U/g Hb where else its value 
on Day 3 was 2.78 U/g Hb (p = 0.002). It 
was also noted that within the storage period 
of seven days, the mean differences of G6PD 
activity between Day 1 and Day 7 was 1.459 
U/g Hb. (p = 0.000).  
The established cut-off points for G6PD 
deficiency for this study was 7.69 U/g Hb 
(60 % of 12.8 U/g Hb; the normal mean ac-
tivity) and 2.56 U/g Hb for severe deficiency 
(20 % of normal mean activity) while the 
range for moderate deficiency (20 % - 60 % 
of normal mean activity). The reference 
ranges were established earlier by Azma et 
al., 2014. Thus, based on the current find-
ings, if there was a reduction of mean G6PD 
activity by 1.459 U/g Hb after seven days of 
collection, partial deficient newborns might 
wrongly be diagnosed as severe G6PD defi-
ciency.  
We have also explored the possibility of 
using air-dried cord blood samples spotted 
on the chromatography paper as a potential 
alternative method of collecting blood and 
transportation. The convenience of this 
method lies in the fact that blood samples 
could be stored at room temperature and 
transported in dry form. It will then provide 
a more practical way for transportation of 
cord blood samples from remote areas which 
may take days to reach UKMMC. However, 
the current study demonstrated that enzyme 
activity on dried blood samples showed a 
significant drop in G6PD activity as early as 
Day 2 of storage. There was statistically sig-
nificant difference in the mean G6PD activi-
ty between Day 1 and Day 2 (13.9 U/g Hb vs 
12.02 U/g Hb, respectively, p < 0.005). Simi-
lar findings were also described by Fujimoto 
et al. (2000), suggesting reduced the G6PD 
enzyme stability in dried blood spot, proba-
bly due to the adversely affected by humidity 
and temperature. 
A comparison on the G6PD enzyme sta-
bility between two different methods of col-
lection and transportation was performed. 
We found that the mean G6PD activity of 
dried blood samples were lower than the 
mean G6PD activity for EDTA tube samples 
beginning even on Day 1 (13.96 U/g Hb vs 
15.9 U/g Hb, p = 0.001) (Table 3). The 
G6PD activities for the dried blood samples 
were significantly lower than the activity for 
the EDTA tube samples on all the 7 days 
(Figure 3). Hence, our findings showed that 
the dried blood samples resulted in lower en-
zyme stability as compared to blood samples 
stored in EDTA tubes. In addition, the en-
zyme activity on air-dried blood spot chro-
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matography paper fluctuated on the first five 
days of analysis, whiles that in EDTA tube 
consistently decreased over the time. The 
possibilities that could have contributed to 
these findings were due to pipetting tech-
nique. EDTA is the one of the recommended 
anticoagulants that can be used to preserve 
the G6PD enzyme in the erythrocytes. Previ-
ous study by Oduola et al. (2005), showed 
that G6PD enzyme was stable for up 72 
hours at 4 °C in EDTA tube, followed by 
ACD, CPD, sodium citrate and lithium hepa-
rin.  
 
CONCLUSION 
The OSMMR-D G6PD assay kit is rapid, 
easy to perform, less laborious and has good 
reproducibility. The maximum days of a 
cord blood sample that can be stored in 
EDTA tube and refrigerated at 2-8 °C to give 
a consistent reading for G6PD assay, was 3 
days. Spotted, air-dried cord blood sample 
showed lower G6PD activity measurement 
hence is not suitable for G6PD enzyme ac-
tivity determination.  
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